ZOLL MEDICAL CORP 4
4 · ZOLL MEDICAL CORP · Filed Apr 30, 2012
Insider Transaction Report
Form 4
SMITH BENSON
Director
Transactions
- Exercise/Conversion
Common Stock
2012-04-26$17.56/sh+2,000$35,120→ 2,000 total - Disposition to Issuer
Common Stock
2012-04-26−2,000→ 0 total - Exercise/Conversion
Common Stock
2012-04-26$11.26/sh+4,000$45,020→ 8,000 total - Disposition to Issuer
Common Stock
2012-04-26$93.00/sh−22,000$2,046,000→ 0 total - Exercise/Conversion
Stock Option
2012-04-26−2,000→ 0 totalExercise: $17.56From: 2003-11-06Exp: 2012-11-06→ Common Stock (2,000 underlying) - Exercise/Conversion
Stock Option
2012-04-26−4,000→ 0 totalExercise: $11.26From: 2006-11-15Exp: 2015-11-15→ Common Stock (4,000 underlying)
Footnotes (3)
- [F1]These restricted stock awards vested in full and were cancelled immediately prior to the effective time of the merger (the "Merger") pursuant to that certain Agreement and Plan of Merger, dated March 12, 2012, by and among ZOLL Medical Corporation, Asahi Kasei Corporation, Asahi Kasei Holdings US, Inc. and Asclepius Subsidiary Corporation (the "Merger Agreement") in exchange for an aggregate cash payment equal to the number of shares of ZOLL Medical Corporation's common stock underlying such restricted stock awards multiplied by the per share purchase price of $93.00.
- [F2]Disposed of at the effective time of the Merger pursuant to the terms of the Merger Agreement.
- [F3]Represents options under ZOLL Medical Corporation's Amended and Restated 2001 Stock Incentive Plan that were either fully exercisable or accelerated in full and exercised pursuant to the terms of the Merger Agreement.